Tracking the Shift: Real-World Adoption of Emerging IHC Markers in Early 2026
Moving beyond the "hype" to seeing actual testing adoption on the ground.
Moving beyond the "hype" to seeing actual testing adoption on the ground.
As Antibody-Drug Conjugates (ADCs) reshape the therapeutic landscape, commercial success depends on...